This inventor holds 2 USPTO granted patents. Top assignee: Clinical Computer Systems Incorporated. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: **Caren Busen: Innovator in Fetal Heart Rate Monitoring**
Introduction
Caren Busen, an inventive mind hailing from Timewell, IL, has made notable contributions to the field of obstetrics through his innovative inventions. With two patents to his name, Busen has developed advanced systems for monitoring fetal health and categorizing heart rate information. His work is especially significant in ensuring the well-being of unborn children.
Latest Patents
Caren Busen's latest patents focus on the automatic categorization and assessment of fetal heart rate data. The first patent details a system and method for documenting and categorizing medical obstetrics data, specifically fetal heart rate characteristics. This invention categorizes fetal heart rate characteristics into three distinct categories:
- **Category I**—strongly predictive of normal fetal acid-base balance,
- **Category II**—not predictive of abnormal fetal acid-base balance,
- **Category III**—predictive of abnormal fetal acid-base balance.
The second patent revolves around an electronic fetal monitoring assessment system and method. This system includes tools that are integral to Electronic Fetal Monitoring (EFM) systems, widely utilized by medical professionals. The assessment tools provide measurements for baseline FHR, variability, decelerations, and accelerations, aiding healthcare providers in evaluating fetal heart rate patterns.
Career Highlights
Caren Busen is currently employed at Clinical Computer Systems Incorporated, where he continues to develop innovative solutions for medical data management. His commitment to advancing fetal monitoring technology has positioned him as a key figure in medical research and invention.
Collaborations
In his career, Busen has collaborated with knowledgeable colleagues such as Randall I. Paul and Lisa A. Miller, who have contributed to his innovative projects. Their teamwork emphasizes the importance of collaboration in the field of medical research and technology.
Conclusion
Caren Busen's dedication to improving fetal health monitoring through innovation is commendable. His two patents reflect a profound understanding of medical needs and technological advancement. As he continues to evolve within the domain of obstetrics, his contributions will undoubtedly play a significant role in enhancing fetal care and monitoring practices.